Company
MapLight Therapeutics
MapLight Therapeutics has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ML-007C-MA | Phase 2 | Psychosis Associated With Alzheimer's Disease |
Latest
No recent events.
Follow MapLight Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.